| Rivopharm SA - Levetiracetam Rivopharm 250, compresse rivestite con film | | 62036 | | 01 | | Levetiracetam Rivopharm 250 | | compresse rivestite con film | | N03AX14 | | Levetiracetam | | 21.03.2012 | | |
| | Composition | | levetiracetamum 250 mg, maydis amylum, povidonum K 30, silica colloidalis anhydrica, talcum, magnesii stearas, coperta: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 132, pro compresso obducto. | | Packungsbestandteile | | compresse rivestite con film | | | | Principe actif | Concentr. |
|---|
| Levetiracetame | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| E 132 | | color. | | E 171 | | color. | | Macrogol | 3350 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Poly(Alcohol Vinylicus) | | coperta | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 008 | 30 | DDP | DDP | B | | Oui |
|
|
